Literature DB >> 8144864

Absence of clinically overt atherosclerotic vascular disease and adverse changes in cardiovascular risk factors in 70 patients with insulinoma.

F Leonetti1, P Iozzo, A Giaccari, P Sbraccia, A Buongiorno, G Tamburrano, D Andreani.   

Abstract

Hyperinsulinemia has been assumed to contribute to the pathogenesis of atherosclerosis. To assess the reliability of such claim we planned a retrospective study on a cohort of patients with pancreatic insulin producing neoplasm. A correlation was sought between fasting insulin plasma levels and the metabolic profile emerging from those parameters known to be cardiovascular risk factors, i.e. plasma triglycerides and cholesterol, insulin resistance, hypertension. Special attention was paid to the duration of disease, because the time exposure to hyperinsulinemia could play an important role in developing cardiovascular disease. Seventy patients, 41 females and 29 males, aged 44.9 +/- 1.96 yr (range 15-80), with surgically proved insulinoma were included in the study. Chronic exposure to hyperinsulinemia was documented through the measurement of insulin plasma levels either in the fasting state or post-prandially, resulting in 44.7 +/- 3.28 and 149.9 +/- 12.22 microU/ml, respectively. Fasting glycemia in average was 45.3 +/- 1.34 mg/dl. Plasma triglycerides and cholesterol concentrations were 136.3 +/- 7.93 and 195.8 +/- 5.18 mg/dl, respectively, their distribution overlapping that anticipated for the general population. No correlation arose between the degree of hyperinsulinemia and the lipidic profile. Preoperative blood pressure was 136.9 +/- 2.87 mmHg, systolic and 81.9 +/- 1.32 mmHg, diastolic. Hypertension was present in 5 (7.1%) out of 70 patients and persisted after tumor removal. A condition of insulin resistance (M = 4.06 +/- 0.4 mg/kg min vs 7.41 +/- 0.21) was documented through the euglycemic hyperinsulinemic clamp technique in 20 patients and showed a positive and significant correlation with fasting insulinemia.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8144864     DOI: 10.1007/BF03348949

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  19 in total

1.  Hyperinsulinaemia is not linked with blood pressure elevation in patients with insulinoma.

Authors:  P T Sawicki; L Heinemann; A Starke; M Berger
Journal:  Diabetologia       Date:  1992-07       Impact factor: 10.122

2.  Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2-year follow-up of the Helsinki Policemen Study population.

Authors:  K Pyörälä; E Savolainen; S Kaukola; J Haapakoski
Journal:  Acta Med Scand Suppl       Date:  1985

Review 3.  Is insulin atherogenic?

Authors:  R J Jarrett
Journal:  Diabetologia       Date:  1988-02       Impact factor: 10.122

4.  Coronary heart disease mortality risk: plasma insulin level is a more sensitive marker than hypertension or abnormal glucose tolerance in overweight males. The Paris Prospective Study.

Authors:  A Fontbonne; G Tchobroutsky; E Eschwege; J L Richards; J R Claude; G E Rosselin
Journal:  Int J Obes       Date:  1988

5.  Increased insulin sensitivity in patients with idiopathic reactive hypoglycemia.

Authors:  G Tamburrano; F Leonetti; P Sbraccia; A Giaccari; N Locuratolo; A Lala
Journal:  J Clin Endocrinol Metab       Date:  1989-10       Impact factor: 5.958

6.  Sodium-lithium countertransport and blood pressure: the Gubbio Population Study.

Authors:  M Laurenzi; M Trevisan
Journal:  Hypertension       Date:  1989-05       Impact factor: 10.190

7.  Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up.

Authors:  A Fontbonne; M A Charles; N Thibult; J L Richard; J R Claude; J M Warnet; G E Rosselin; E Eschwège
Journal:  Diabetologia       Date:  1991-05       Impact factor: 10.122

8.  Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations.

Authors:  T A Welborn; K Wearne
Journal:  Diabetes Care       Date:  1979 Mar-Apr       Impact factor: 19.112

9.  Hyperinsulinaemia is not a major coronary risk factor in elderly men. The study of men born in 1913.

Authors:  L Welin; H Eriksson; B Larsson; L O Ohlson; K Svärdsudd; G Tibblin
Journal:  Diabetologia       Date:  1992-08       Impact factor: 10.122

10.  Experimental atherosclerosis-like lesions induced by hyperinsulinism in Wistar rats.

Authors:  Y Sato; S Shiraishi; Y Oshida; T Ishiguro; N Sakamoto
Journal:  Diabetes       Date:  1989-01       Impact factor: 9.461

View more
  6 in total

Review 1.  Cardiovascular impact of drugs used in the treatment of diabetes.

Authors:  Chris R Triggle; Hong Ding
Journal:  Ther Adv Chronic Dis       Date:  2014-11       Impact factor: 5.091

2.  Insulin-like growth factor-1 receptor expression masks the antiinflammatory and glucose uptake capacity of insulin in vascular smooth muscle cells.

Authors:  Niels Engberding; Alejandra San Martín; Abel Martin-Garrido; Mitsuhisa Koga; Lily Pounkova; Erin Lyons; Bernard Lassègue; Kathy K Griendling
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-01-02       Impact factor: 8.311

3.  Chronic primary hyperinsulinaemia is associated with altered insulin receptor mRNA splicing in muscle of patients with insulinoma.

Authors:  P Sbraccia; M D'Adamo; F Leonetti; S Caiola; P Iozzo; A Giaccari; A Buongiorno; G Tamburrano
Journal:  Diabetologia       Date:  1996-02       Impact factor: 10.122

4.  Paroxysmal Hypertension Induced by an Insulinoma.

Authors:  Ko Harada; Yoshihisa Hanayama; Kou Hasegawa; Masaya Iwamuro; Hideharu Hagiya; Ryuichi Yoshida; Fumio Otsuka
Journal:  Intern Med       Date:  2017-02-15       Impact factor: 1.271

Review 5.  Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review.

Authors:  Steve Fordan; Philip Raskin
Journal:  Vasc Health Risk Manag       Date:  2009-04-08

6.  Long-term morbidity and mortality in patients diagnosed with an insulinoma.

Authors:  Elina Peltola; Päivi Hannula; Heini Huhtala; Saara Metso; Juhani Sand; Johanna Laukkarinen; Mirja Tiikkainen; Jukka Sirén; Minna Soinio; Pirjo Nuutila; Leena Moilanen; David E Laaksonen; Tapani Ebeling; Johanna Arola; Camilla Schalin-Jäntti; Pia Jaatinen
Journal:  Eur J Endocrinol       Date:  2021-09-01       Impact factor: 6.664

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.